KAMILAH GRISWOLD: Open Payments
NPI 1669238994 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 37 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,228 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $452 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $170 |
| Novo Nordisk Inc | 7 | $146 |
| Lilly USA, LLC | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Lundbeck LLC | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 1 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $34 |
| Exact Sciences Corporation | 2 | $30 |
Products named: QULIPTA, Kerendia, VRAYLAR, Ozempic, MOUNJARO, REXULTI, AIRSUPRA, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
